Skip to content
2.52.52.5JPJPJP

Drawing based on the description in the official product monograph. No photo yet.

“6 . DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. . Table 1 -. Dosage Forms, Strengths,. Composition and Packaging Route of Administration Oral Dosage Form/ Strength/. Composition Film-coated tablets; 2.5 mg letrozole Non-medicinal Ingredients Colloidal anhydrous silica, hypromellose, iron oxide red, iron oxide yellow, lactose monohydrate, magnesium stearate, microcrystalline cellulose, poly”

2.5 JP pill

Pill with imprint 2.5 JP is red & yellow, round and has been identified as Letrozole 2.5 mg. It is used for breast cancer. It is supplied by Jamp Pharma Corporation.

Sold in Canada

Letrozole 2.5 mg

Brand
Jamp Letrozole Tablets
Imprint
2.5 JP
Strength
2.5 mg
Used for
Breast cancer
Color
Red, Yellow
Shape
Round
Form
Tablet
Manufacturer
Jamp Pharma Corporation
Drug class
Breast cancer medicine (aromatase inhibitor)
Sold in
Canada
DIN
02541912

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Letrozole pills and guides

What is Letrozole used for?

Letrozole is used for breast cancer.

Medicine type
Breast cancer medicine (aromatase inhibitor)
Official uses from the US prescribing label

Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Extended Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.

First and Second-Line Treatment of Advanced Breast Cancer

Letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. Letrozole tablets are also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

From the FDA-approved label on DailyMed (published Aug 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 2.5 JP. The parts can be split between the two sides, so turn the pill over and check both.
  • It is red & yellow, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Jamp Letrozole Tablets by Jamp Pharma Corporation.

In Canada: prescription only.

Ingredients

Active: Letrozole

Other pills with imprint 2.5 JP

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Letrozole pills